Jeffrey Miceli - Concepedia

Author

Jeffrey Miceli

Pfizer (United States)

Also Known As

JEFFREY J. MICELI, Jeffrey J Miceli, Jeffrey J. Miceli, Jeffrey Miceli

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Johns Hopkins University University of Cincinnati Medical Center

About

Jeffrey Miceli is an author at Pfizer (United States) specializing in pharmacotherapy, medicine, and psychopharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	674
2	Social Sciences	4	4	179
3	Anesthesia	1	1	29
4	Biochemistry	1	1	13
5	Metabolism	1	1	13

Jeffrey Miceli

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
A Randomized Evaluation of the Effects of Six Antipsychotic Agents on QTc, In the Absence and Presence of Metabolic Inhibition Edmund P. Harrigan, Jeffrey Miceli, Richard Anziano, Journal of Clinical Psychopharmacology Randomized EvaluationPsychoactive DrugMean Qtc IntervalsQtc ProlongationPsychiatry	2004	357
Comparison of Pregabalin with Pramipexole for Restless Legs Syndrome Richard P. Allen, Crystal Chen, Diego García‐Borreguero, New England Journal of Medicine	2014	231
A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome Richard P. Allen, Crystal Chen, Adina Soaita, Sleep Medicine Translational PharmacologyMedicineRestless LegsClinical PharmacologyPharmacotherapy	2010	99
Pregabalin Versus Pramipexole: Effects on Sleep Disturbance in Restless Legs Syndrome Diego García‐Borreguero, Jeffrey Patrick, Sarah Dubrava, SLEEP	2014	92
Tolerability of Oral Ziprasidone in Children and Adolescents with Bipolar Mania, Schizophrenia, or Schizoaffective Disorder Melissa P. DelBello, Mark Versavel, Kathleen Ice, Journal of Child and Adolescent Psychopharmacology	2008	75
Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment Karl Rickels, Thomas Shiovitz, Tanya Ramey, International Clinical Psychopharmacology PsychotherapyPsychotropic MedicationPsychopharmacologyNeuropsychiatryPharmacotherapy	2012	66
The Effect of Timing of a Standard Meal on the Pharmacokinetics and Pharmacodynamics of the Novel Atypical Antipsychotic Agent Ziprasidone Bettina A. Hamelin, S Allard, Louis Laplante, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	1998	61
Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: A randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder Jeffrey Miceli, Thomas G. Tensfeldt, Thomas Shiovitz, Clinical Therapeutics PsychiatryPsychotic DisorderQtc IntervalPsychopharmacologySchizophrenia	2010	44
Effects of Oral Ziprasidone and Oral Haloperidol on QTc Interval in Patients with Schizophrenia or Schizoaffective Disorder Jeffrey Miceli, Thomas G. Tensfeldt, Thomas Shiovitz, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2010	42
Pharmacodynamics of Ziprasidone in Children and Adolescents: Impact on Dopamine Transmission Floyd R. Sallee, Donald L. Gilbert, Alexander A. Vinks, Journal of the American Academy of Child & Adolescent Psychiatry Psychoactive DrugAddictionDopamine TransmissionMedicinePsychotropic Medication	2003	40

Page 1